These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33557636)

  • 21. Preoperative Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Locally Advanced Distal Rectal Cancer.
    Yang Y; Liu Q; Jia B; Du X; Dai G; Liu H; Chen J; Zeng M; Wen K; Zhu Y; Wang Y; Feng L
    Technol Cancer Res Treat; 2019 Jan; 18():1533033818824367. PubMed ID: 30803368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study of a new therapeutic approach in the treatment of locally advanced stages of rectal cancer: neoadjuvant radiation, chemotherapy and regional hyperthermia.
    Riess H; Löffel J; Wust P; Rau B; Gremmler M; Speidel A; Schlag P
    Eur J Cancer; 1995; 31A(7-8):1356-60. PubMed ID: 7577051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Modulated Electro-Hyperthermia (mEHT) on Two and Three Year Survival of Locally Advanced Cervical Cancer Patients.
    Minnaar CA; Maposa I; Kotzen JA; Baeyens A
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heat shock factor 1 inhibition enhances the effects of modulated electro hyperthermia in a triple negative breast cancer mouse model.
    Viana PHL; Schvarcz CA; Danics LO; Besztercei B; Aloss K; Bokhari SMZ; Giunashvili N; Bócsi D; Koós Z; Benyó Z; Hamar P
    Sci Rep; 2024 Apr; 14(1):8241. PubMed ID: 38589452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial.
    Arbea L; Martínez-Monge R; Díaz-González JA; Moreno M; Rodríguez J; Hernández JL; Sola JJ; Ramos LI; Subtil JC; Nuñez J; Chopitea A; Cambeiro M; Gaztañaga M; García-Foncillas J; Aristu J
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):587-93. PubMed ID: 22079731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential enhancement of host immunity and anti-tumor efficacy of nanoscale curcumin and resveratrol in colorectal cancers by modulated electro- hyperthermia.
    Kuo IM; Lee JJ; Wang YS; Chiang HC; Huang CC; Hsieh PJ; Han W; Ke CH; Liao ATC; Lin CS
    BMC Cancer; 2020 Jun; 20(1):603. PubMed ID: 32600429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Capecitabine (Xeloda) vs. Combination of Capecitabine and Oxaliplatin (XELOX) as Neoadjuvant CRT for Locally Advanced Rectal Cancer.
    Yaghobi Joybari A; Azadeh P; Babaei S; Hosseini Kamal F
    Pathol Oncol Res; 2019 Oct; 25(4):1599-1605. PubMed ID: 30712194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
    Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
    Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor response and negative distal resection margins of rectal cancer after hyperthermochemoradiation therapy.
    Tsutsumi S; Tabe Y; Fujii T; Yamaguchi S; Suto T; Yajima R; Morita H; Kato T; Shioya M; Saito J; Asao T; Nakano T; Kuwano H
    Anticancer Res; 2011 Nov; 31(11):3963-7. PubMed ID: 22110227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined treatment with modulated electro-hyperthermia and an autophagy inhibitor effectively inhibit ovarian and cervical cancer growth.
    Yang W; Han GH; Shin HY; Lee EJ; Cho H; Chay DB; Kim JH
    Int J Hyperthermia; 2019; 36(1):9-20. PubMed ID: 30428738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of modulated electro-hyperthermia on local disease control in HIV-positive and -negative cervical cancer women in South Africa: Early results from a phase III randomised controlled trial.
    Minnaar CA; Kotzen JA; Ayeni OA; Naidoo T; Tunmer M; Sharma V; Vangu MD; Baeyens A
    PLoS One; 2019; 14(6):e0217894. PubMed ID: 31216321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical study on locally advanced rectal cancer patients with pathological complete response after neoadjuvant chemoradiotherapy].
    Chen G; Zhang R; Wu X; Lu Z; Ding P; Pan Z; Wan D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):664-7. PubMed ID: 27353101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison and effect-to-treatment analysis.
    Roussakow SV
    BMJ Open; 2017 Nov; 7(11):e017387. PubMed ID: 29102988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcomes of mild hyperthermia for locally advanced rectal cancer treated with preoperative radiochemotherapy.
    Kang MK; Kim MS; Kim JH
    Int J Hyperthermia; 2011; 27(5):482-90. PubMed ID: 21756045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series.
    De Bari B; Franzetti-Pellanda A; Saidi A; Biggiogero M; Hahnloser D; Montemurro M; Bourhis J; Zeverino M; Ozsahin M
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):1075-1084. PubMed ID: 30830296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 38. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
    Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M
    Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Concomitant Radiation Boost in Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Badakhshi H; Ismail M; Boskos C; Zhao K; Kaul D
    Anticancer Res; 2017 Jun; 37(6):3201-3205. PubMed ID: 28551665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer.
    Mehta VK; Poen J; Ford J; Edelstein PS; Vierra M; Bastidas AJ; Young H; Fisher G
    Dis Colon Rectum; 2001 Jan; 44(1):52-8. PubMed ID: 11805563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.